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Drug Overdose Deaths in Halifax, Nova Scotia from 1996 to 2010: 
A Descriptive and Comparative Study 
 




Drug overdose death is an increasing concern in many areas of the world and 
many prevention programs exist to control these deaths. These include prescription 
monitoring programs, Naloxone treatment, safer injection facilities and methadone 
treatment. It is prescription drug overdose deaths which are becoming more prevalent and 
therefore these prevention programs must be adjusted to fit the on going problems. This 
can be done by examining trends in overdose deaths. The purpose of this study is to 
examine drug overdose deaths in Halifax, Nova Scotia, between 1996 and 2010 with 
respect to death rate, drug prevalence and manner of death. This data is compared to a 
previous study in Halifax from 1993 to 1995. It was found that death rates (per 100,000 
persons) due to drug overdose have increased since 1993. Narcotic analgesics and 
benzodiazepine were the most prevalent drug categories found in toxicology reports and 
also increased significantly between the two studies. Cocaine usage also increased. In 
manner of death comparison a significant decrease in undetermined deaths was seen with 
a simultaneous increase in accidents. Based on this drug overdose death data, focus can 
be directed to the areas which are increasing the most, i.e. prescription drug use, as well 
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1. Introduction and Literature Review 
1.1 Drug Overdose Deaths 
A drug overdose is characterized as the use of a drug or medicine in a greater 
quantity than is recommended or that is safe (Patel et al., 2008). An overdose can cause 
harmful symptoms, which can vary depending on the person and amount of drug taken. 
Variation occurs due to pharmacokinetic properties; how the body absorbs, distributes, 
metabolizes and excretes the drug, and pharmacodynamic properties; how the drug affects 
the body based on receptor interaction. Each one of these processes can vary greatly 
between people and the drug that is being taken. Tolerance, which is the decrease in 
susceptibility to the effects of a drug through prolonged use, also affects drug reactions. It 
is because of these processes that not all doses of the same drug cause the same effect. 
Death may result from a combination of these processes or from a single or combination 
of drugs as well as the interactions between drugs (Golan et al., 2008). 
Deaths caused by drug overdose have increased over the past few years and are a 
major issue in many parts of the world including Canada and the United States. For 
example, in New York City (NYC), drug overdose surpassed homicide as the number one 
cause of accidental death between 1990 and 1998 (Kerr et al., 2006). It became the 
number one cause of accidental death in the United States (US) in 2009, killing more 
people than motor vehicle accidents (Brandeis University, 2011). Although there is not as 
much data collected for Canada, drug overdose death is thought to be a significant 
problem. From 1992 to 2004, it was estimated that 500 to 1000 drug-related overdose 
deaths were reported annually in Canada (Fischer et al., 2006 a). From 1993 to 1995, 







rate of 4.1 deaths per 100,000 persons per year (Poulin et al., 1998).  
Not only are the number of overdose deaths alarming but they are increasing at a 
significant rate. From 1990, death rate due to drug overdose in the US has increased by 
300%, resulting in a total of 37,000 deaths in 2009 (Centers for Disease Control and 
Prevention, 2012 b). In Utah the number of drug poisonings (not limited to deaths) 
between 1991 and 2003 increased by a factor of five (Centers for Disease Control and 
Prevention, 2005), while in Florida the death rate of drug overdose increased 47.5% in a 
six year period (2003-2009) (Centers for Disease Control and Prevention, 2011a). 
Immediate attention is drawn to the issue of drug overdose death in communities based on 
these findings. 
Several different drugs are responsible for deaths caused by overdose, as well as 
many different combinations of these drugs (Coffin et al., 2003). Opioids are one of the 
major drug categories which cause accidental overdose deaths (Coffin et al., 2003; Fisher 
et al., 2006b). In NYC, opioids were found in toxicology results of 71.1% of those who 
died of accidental drug overdose (Coffin et al., 2003). In the United States the rate of 
prescription opioid abuse surpassed that of heroin from 2002 to 2006 (Fischer et al., 2006 
b). Alcohol is also found in the toxicology reports of a large number of drug overdose 
deaths. From 1990 to 1998, 40.4% of persons that died due to drug overdose in NYC had 
alcohol in the toxicology reports (Coffin et al., 2003) and in Wales 29% of deaths in 2002 
were alcohol-related (Webb et al., 2003). Another drug which causes a significant number 
of unintentional drug overdose deaths is cocaine. In NYC, deaths attributed to cocaine 
peaked from 1993 to 1995 (10.35, 9.64 and 10.17 drug overdose deaths per 100,000 







Between 1990 and 1998, 69.5% of overdose deaths were attributed to cocaine (Coffin et 
al., 2003). In New Mexico, cocaine was implicated in 37.6% of unintentional drug 
overdose deaths between 1990 and 2005 (Shah et al., 2007) while in Wales it was 
implicated in only 4% of all drug overdose deaths in 2000 (Webb et al., 2003).  
 Medical examiners and coroners generally categorize drug overdose deaths into 
accidental, suicide and undetermined manners of death. Correct classification is important 
for many reasons, including for insurance and public health policies. There is 
considerable variation in the assessment of manner of death. Suicides differ from 
accidents because they are purposely committed by the deceased and are generally 
underreported (Lindqvist and Gustafsson, 2002). Suicides have many biological and 
psychological (i.e. depression) factors which affect the investigation (Shields et al., 2005) 
making a positive determination of suicide highly variable among medical examiners 
(Shah et al., 2007). Medical examiners only categorize a death as undetermined if they 
have little evidence to discriminate between an accident or suicide (Lindqvist and 
Gustafsson, 2002). Unintentional overdose deaths (accidental deaths) have been 
increasing in many areas, including New Mexico from 1990-2005 (Shah et al., 2007) and 
New York City from 1990-1993 (Coffin et al., 2003). They are also the primary cause of 
death in illicit drug users throughout the world (Shah et al., 2007). 
1.2 Overdose Prevention 
There are many different preventative techniques in place which attempt to 
decrease the number of overdose deaths (Kerr et al., 2006). One approach is that of harm 
reduction which focuses on the problems of the user rather than their specific drug use. 







drug usage immediately. Harm reduction includes using outreach programs to educate 
users on the harms and potential deadly outcomes of drug use by attempting to limit the 
users’ need for drugs (Cheung, 2000). The problem with this type of program is that once 
users are no longer in treatment, they can resort back to their old habits, which increases 
their risk of death due to overdose (Hickman et al., 2007). There are also prescription 
monitoring programs which attempt to regulate the intentional overuse of prescription 
drugs by monitoring the amount of drugs given to patients by pharmacists and doctors 
(Nova Scotia Prescription Monitoring Program). These efforts help prevent the 
purposeful misuse of a prescription drug (Canadian Center on Substance Abuse, 2012), 
but have no effect on their accidental misuse. 
Differing from substance abuse and rehab programs which aid in the prevention of 
harm from all drugs, there are new programs focusing on harm reduction of specific types 
of drugs, like opioids and injection drugs. In 2003, North America’s first ever supervised 
safer injection facility was established in Vancouver (Kerr et al., 2006). This program has 
been shown to reduce the number of overdose deaths caused by the injection of drugs 
(Fischer et al., 2006 a; Kerr et al., 2006; Milloy et al., 2008). Supervised safer injection 
facilities are areas in which drug users can inject drugs (licit and illicit), which they 
procure under the supervision of medically trained personnel (Kerr et al., 2006; Milloy et 
al., 2008).  By having medically trained personnel available, overdoses can be treated 
before they become fatal.  
Many areas of the world are also using the distribution of Naloxone to prevent 
overdose deaths (Centers for Disease Control and Prevention, 2012a; Fischer et al., 







reverses the respiratory depression caused by overdose of any opioid drug (Centers for 
Disease Control and Prevention, 2012a; Fischer et al., 2006a). Through training sessions 
and the distribution of prescriptions for Naloxone to opioid drug users, many overdose 
deaths can be prevented (Piper et al., 2007).  
Another form of drug harm reduction is the use of methadone maintenance 
programs (Cheung, 2000). Methadone is a treatment for opioid addiction, especially 
heroin, and is given to users on a strict schedule (Drucker et al., 1998). This program 
prevents the symptoms caused by withdrawal, which leads users to continue heroin use to 
avoid the negative affects, and it is also used for detoxification (Drucker et al., 1998; 
Langendam et al., 2001). Although this program does help, methadone is still a 
potentially addictive drug and can cause overdose deaths on its own if not monitored 
strictly by pharmacists (Williamson et al., 1997).  
Though all these programs are helpful, the large majority of them focus mainly on 
the use of illegally obtained drugs. For example, the studies done on Naloxone and  
supervised safer injection facilities focus mainly on opioid injection drugs such as heroin 
(e.g. Milloy et al., 2008; Piper et al., 2007). These illegally obtained drugs, which include 
heroin, cocaine, hallucinogens and stimulants, cause a considerable number of overdose 
deaths (e.g. in the US there are 2.8 overdose deaths per 100,000 persons due to illegally 
obtained drugs) (Centers for Disease Control, 2011b), but they are not the most 
concerning cause of drug overdoses. In British Columbia, there has been a downward 
trend in overdose deaths caused by the use of illegally obtained drugs since 1998 (British 
Columbia Coroner’s Service, 2011). According to the Canadian Center on Substance 







to 2002, there was an increase in the amount of prescription drugs in Canada (Morgan, 
2004). This is also true in the United States where the death rate for prescription drug 
overdose is 6.5 deaths per 100,000 persons per year (Centers for Disease Control and 
Prevention, 2011 b). In Florida, the death rate involving prescription drugs was four times 
that of illegally obtained drugs (e.g. heroin and cocaine). Deaths due to prescription drugs, 
in Florida, increased between 2003 and 2009 by 84.2% and accounted for 76.1% of all 
overdose deaths (Centers for Disease Control and Prevention, 2011 a). This trend was 
also seen in Kentucky (Centers for Disease Control and Prevention, 2011 a). In Hamilton 
Ontario, prescription drug overdose deaths accounted for 72% of all overdose deaths in 
1967 (Sims et al., 1973).   
1.3 Uses for Drug Overdose Data 
Reducing drug overdose deaths must involve a more intensive public health 
approach, paying attention to both illegally obtained and prescription drugs (Shah et al., 
2007).  The prevention programs and interventions should be tailored to specific trends in 
overdose death rates and different drug combinations in a given area (Coffin et al., 2003; 
Fischer et al., 2004; Shah et al., 2007). Drug-related mortality studies provide important 
information on drug use and practices which can then be used to monitor drug policy, 
prescription practices and the effectiveness of treatment programs (Webb et al., 2003) as 
well as future overdose death rates (Coffin et al., 2003). 
1.4 Drug Overdose data collection in Canada 
 There are very few estimates of mortality due to drug overdose in Canada (Single 
et al., 2000), with the majority of information derived from Ontario and British Columbia. 







determine patterns of drug overdose. From 1993 to 1995 there was an in-depth study done 
by Poulin et al. (1998) which examined drug overdose deaths in Halifax, Nova Scotia. 
The authors report 48 deaths caused by drug overdose during the three year period, which 
represents approximately 14 deaths per year and a rate of 4.1 deaths per 100,000 persons 
per year. Of these 48 deaths, only five had illicit drugs in their toxicology reports and of 
these, only three contained cocaine (7.1% of all overdose deaths). The most commonly 
observed drug category in the toxicology results of victims of drug overdose was ethanol 
(47.6%). Psychotropic medications (antidepressants, benzodiazepines, antipsychotics, and 
hypnotics and sedatives) were found in 62% of drug overdose deaths. Poulin et al. (1998) 
also found that suicide was the most common manner of death, attributing to 47.6% of all 
drug overdose deaths. The majority of suicides were committed by females (65%). 
Undetermined manner of death was the second most common, comprising 45.2% of all 
drug overdose deaths.  
1.5 Objectives 
The objectives of this study were to:  
1) Examine the trends in drug overdose death rates between 1996 and 2010 and to 
determine if these trends changed significantly within this study period. 
2) Determine which types of drugs were the most prevalent in the toxicology results 
between 1996 and 2010. 
3) Examine the trends in cocaine prevalence in toxicology reports of people dying of 
drug overdose between 1996 and 2010. 
4) Examine any the trends in the manner of death (accidental vs. suicide vs. 







These data will be compared to those of Poulin et al. (1998) to determine whether 





























The study was aligned in design with that done by Poulin et al. (1998) to permit 
comparison over two sampling periods. All data were collected from the Nova Scotia 
Medical Examiner Service (NSMES) in Halifax, Nova Scotia, Canada (44.6°N, 63.6°W) 
using compiled spreadsheets and case files for mortality data collected between 1996 and 
2006. Data collected from 2007 to 2010 were compiled in a spreadsheet by the 
information technology department of the NSMES. Cause of death was noted. If death 
was due to drug overdose, the case number, date of death, age, manner of death, cause of 
death, sex, toxicology results, place of residence (where they are living) at death and 
place of death (where they were found deceased) were recorded. This study was focused 
on people who lived and died in Halifax, Nova Scotia. 
Dr. Matt Bowes, Chief Medical Examiner, checked the data to insure that all 
recorded deaths were caused by a drug overdose. Any deaths that he did not believe to be 
a direct result of drug overdose were not included in this analysis.  
2.1 Death Rates 
Halifax’s population size was regressed against year between 1981 and 2010 
(Statistics Canada). Population size for a given year was interpolated from the generated 
equation (Appendix A). Death rates due to drug overdose per 100,000 persons were 
calculated by dividing the total number of drug overdose deaths (D) (Appendix B) by the 
population of Halifax for that year (P) and then multiplying by 100,000 [i.e. 









2.2 Prevalence of Drugs 
The types of drugs found in toxicology reports were split into fifteen different 
categories. Twelve of these categories were based on the previous study done by Poulin et 
al. (1998) to enable comparison. Categories included are listed in Table 1. The other three 
categories (stimulants, carbon monoxide and hallucinogens) were added based on the 
drugs that were found in the more recent toxicology reports that had not been included in 
the results of Poulin et al. (1998). To provide an in depth look at cocaine as well as to 
ensure comparison, cocaine was left as its own category and added to the stimulants 
category. Classifications were constructed according to Berardi et al. (2009) and Lacy et 
al. (2010), and were examined by the Chief Medical Examiner of Nova Scotia, Dr. Matt 
Bowes (list of drugs along with their metabolites can be found in Appendix C).  
The toxicology results from each case were examined and a category of drug was 
considered present if one or more drugs from that category were found in the results. The 
totals were then calculated for each year, and added together for an overall total over all 
15 years. The percentage of cases which contained each drug category were then 
calculated ([prevalence/total overdoses]*100).  
2.3 Manner of Death 
The trends in manner of death (suicide, accident or undetermined) were graphed 
as to the percent of deaths caused by each manner of death for each year between 1996 
and 2010. Percent of deaths was calculated by dividing the number of drug overdose 
deaths deemed with the manner of death by the total of overdose deaths (Appendix B) 








2.4 Statistical Analysis 
 Data was tested for normality using D’Agostino & Pearson omnibus normality 
test (GraphPad software, Inc, 2013). To assess change in death rate between the first half 
of the study (1996-2002) and the second half (2003-2010), a Mann Whitney test was 
performed. Prevalence of drug categories in this study was determined using a goodness 
of fit test calculated by hand and comparison between the two studies was done through 
chi-squared testing (numbers were moved one place to avoid decimals). Chi-squared 
testing was also done to view changes in manner of death. All tests (except the goodness 
of fit test) were done using graphPad (GraphPad software, Inc, 2013) and all results were 





















3.1 Death Rates due to Drug Overdose 
The death rate per 100, 000 persons due to drug overdose in Halifax were 
significantly higher in the last eight years of the study compared to the first seven years 
(8.95 deaths per 100,000 ± 0.75, n= 8 vs. 6.46 deaths per 100,000 ± 0.49, n=7 
respectively; Mann-Whitney U= 9.00, p= 0.03). The death rates due to drug overdose 
began with an increase from 6.73 to 8.32 drug overdose deaths per 100, 000 persons in 
1998. The rate then decreased to a low of 4.78 in 2000. There has been an increase in 
death rate since then with a major spike in 2007 with 11.61 deaths per 100, 000 persons 
(Figure 1). In 2007 a decrease began and has continued to decrease to 8.99 drug overdose 
deaths per 100,000 people at the end of the study (2010) (Figure 1).  
The average death rate also increased in comparison with the previous study from 
1993 to 1995 by Poulin et al. (1998). There were 4.1 deaths/100,000 (ranged from 3.50 - 
4.67) in that study and 7.79 deaths/100,000 (ranged from 4.78 - 11.61) from 1996 to 2010. 
3.2 Prevalence of Drug Categories 
There was a significant difference in prevalence between drug categories 
(χ
2
=689.35, df= 14, P< 0.0001). Toxicology reports show that narcotic analgesics were 
the most frequent category of drugs used while hallucinogens were the least (Table 1).  
There was a significant change in drug prevalence between Poulin et al.’s study 
(1998) and this study (χ
2
=495, df=14, P<0.0001). Prevalence was typically higher in this 
study than Poulin et al.’s (1998) with nine of the fifteen categories showing an increase in 
prevalence. Benzodiazepines and cocaine had increased the most. There were also three 







include cocaine, carbon monoxide and hallucinogens); therefore, drugs from these 
categories have increased from zero usage (Table 2).  
3.3 Prevalence of Cocaine 
The prevalence of cocaine in toxicology reports of drug overdose deaths 
fluctuated between 1996 and 2010 with major peaks in 1998, 2002 and 2007 (34%, 
33.3% and 31.8% of drug overdose deaths, respectively) (Figure 2). Despite these 
fluctuations, there has been a general increase in cocaine found in toxicology reports of 
drug overdose death (4.3 % in 1996 to 20% in 2010) (Figure 2). 
Poulin et al. (1998) found that 7.1% of persons that died from drug overdose had 
cocaine in their toxicology reports (range was not provided). This study found that 20.2% 
of persons that died of drug overdose had cocaine in their toxicology reports (range 3.7 to 
34%).  
3.4 Manner of Death 
Manner of death for drug overdose deaths varied over the 15 year period (Figure 
3). Suicides fluctuated throughout the study with a high in 1999 and a low in 2005. 
Suicides were on a decreasing trend for the last five years (48.7% in 2006 to 25.7% in 
2010). Undetermined drug overdose deaths have decreased resulting in a minimum of 
zero in 2005, 2006, 2007 and 2008, while accidental drug overdose deaths have increased 
with a maximum of 84% in 2005. 
A significant difference in the mean number of accidental, suicidal and 
undetermined deaths between the two studies was found (χ
2















Figure 1: The trend in death rate (per 100,000 persons) of individuals, in Halifax N.S., 




















Table 1: Prevalence of drug categories, total number and percent of total deaths, in the 




Percent of Total 
overdoses* 
Narcotic analgesics 196 45.6 
Benzodiazepines 182 42.3 
Ethanol 171 39.8 
Antidepressants 164 38.1 
Medications available without prescription 119 27.7 
Stimulants (including cocaine) 100 23.3 
Cocaine 87 20.2 
Other prescription medications 79 18.4 
Miscellaneous 56 13.0 
Cannabis 43 10.0 
Carbon Monoxide 39 9.1 
Hypnotics and sedatives 38 8.8 
Drugs for major psychiatric or neurologic disorders 37 8.6 
Other Alchohol 15 3.5 
Hallucinogens 2 0.5 



















Table 2: Comparison of prevalence of drug categories in the toxicology reports of 
overdose deaths in the previous study by Poulin et al. (1998) and this study. 
Drug Class 
Percent of Total from 
Poulin et al.(1998)* 
Percent of Total 
from 1996-2010* 
Narcotic analgesics 23.8 45.6 
Benzodiazepines 19 42.3 
Ethanol 47.6 39.8 
Antidepressants 38.1 38.1 
Medications available without prescription 28.6 27.7 
Stimulants (including cocaine) N/A 23.3 
Cocaine 7.1 20.2 
Other prescription medications 9.5 18.4 
Miscellaneous 7.1 13.0 
Cannabis 4.8 10.0 
Carbon Monoxide N/A 9.1 
Hypnotics and sedatives 11.9 8.8 
Drugs for major psychiatric or neurologic disorders 11.9 8.6 
Other Alchohol 7.1 3.5 
Hallucinogens N/A 0.5 




















Figure 2: The prevalence of cocaine found in the toxicology reports of overdose deaths in 




















Table 3: Comparison of manner of death between a study by Poulin et al. (1998) (1993-
1995) and this study (1996-2010). 
 1993-1995 1996-2010 
Accidental 7.1% 42.8% 
Suicide 47.6% 42.3% 


























































Figure 3: The trends in manner of death, suicide, accidental, undetermined, by percentage 
















The death rate due to drug overdose increased significantly from 1993 to 2010 in 
Halifax, N.S. This is shown through the comparison between the study done by Poulin et 
al. (1998) with a mortality rate of 4.1 drug-overdose deaths per 100, 000 persons per year 
(1993-1995) compared to the average drug overdose death rate of 7.79 deaths per 100,00 
per year in this study (1996-2010). Although statistical analysis could not be done 
between these two studies, there was an increase in death rate, almost doubling, with no 
overlap between the ranges. This increase in death rate continued throughout the current 
study until 2007 where it began to decrease (Figure 1) but it did not affect the increase of 
drug overdose death rate that was observed in the second half of the study. This general 
increase in drug overdose death rate during these years is consistent with other areas such 
as New York City and the rest of the United States from 1990 to 2009 (Brandeis 
University, 2011; Kerr et al., 2006). A full comparison of my study to many of the other 
studies conducted on drug overdoses is difficult due to different areas of study and 
variations in drug categories. Many studies on drug overdose typically only include data 
of accidental manner of death, such as the ones for the US (Brandeis University, 2011). 
By limiting their investigation into drug overdose deaths they are not able to view general 
trends which allow focus on specific and important areas of interest. Because an increase 
in drug overdose deaths is observed in many different areas, it is a concern that must be 
addressed when dealing with health issues. 
 Four categories of drugs were more prevalent in toxicology results than expected 
(Table 1). The most prevalent category was that of narcotic analgesics, which include 







relieve the sensation of pain (Golan et al., 2008). Benzodiazepines were also a prevalent 
category. This category includes a wide variety of drugs that are prescribed for anxiety 
(Golan et al., 2008). Ethanol and antidepressants were also prevalent. Many different 
types of antidepressants are used to treat depression. Classifying the drugs into only one 
drug category is difficult because many of them are used to medicate more than one 
condition. For example, many benzodiazepines are prescribed as sedatives (which is 
another category of drugs in this study), muscle relaxants and anti-convulsion medication 
(Golan et al., 2008). In many studies of accidental overdose, deaths due to opioids 
(narcotic analgesic category) and alcohol were among the most frequent causes of death 
(Coffin et al., 2003; Fischer et al., 2006 b; Webb et al., 2003), this is also consistent with 
my findings. Most of the drugs found in these categories are either legal to purchase (e.g. 
alcohol) or are available by prescription. My findings indicate that prescription and other 
legal drugs have surpassed illegally obtained drugs in overdose deaths. 
Narcotic analgesics and benzodiazepines increased significantly between the two studies 
situating them in the top two most prevalent drug categories (Table 2). This rise in 
popularity may be for many reasons such as an increase or decrease in the availability of 
other drugs. Two other categories of drugs which also gained popularity were cocaine, 
which is generally obtained illegally, and other prescription medications that do not fit in 
the other categories (Table 2).  
Cocaine was present in the toxicology reports of three of the 42 deaths (7.1%) that 
were investigated by Poulin et al. (1998), which is low for a popular recreational drug 
(Siegel, 1977). Between the two studies there was an increase in the prevalence of 







to trends for deaths in New York during their peak of 69.5% from 1993 to 1995 (Coffin et 
al., 2003) and New Mexico with 37.6% from 1990 to 2005 (Shah et al., 2007). These 
results only portray accidental overdose deaths. In Wales in 2000, only 4% of all drug 
overdose deaths involved cocaine. These results vary widely in different populations, 
though they do show a general increase throughout this variation (Figure 2). 
Comparing the manners of death (accidental, suicide and undetermined) to the 
study done by Poulin et al. (1998), a significant difference was found, with a drastic 
increase in accidental deaths (8.7% in 1996 and 71.4% in 2010). A corresponding 
decrease in undetermined deaths, dropping to zero in 2005 with only a variation of 
approximately 3% was also found. This drastic change in manner of death corresponds to 
the addition of the current Chief Medical Examiner at the NSMES, Dr. Matt Bowes. He 
joined the NSMES in 2004 and was appointed chief in 2006, where he undertook a more 
thorough and accurate approach to the determination of manner of death (Bowes). This 
limited the number of undetermined deaths, which is only used when they cannot 
determine true manner of death (Lindqvist and Gustafsson, 2002). Although there is no 
significant change in the percent of suicides between the two studies, there were 
differences in the criteria which were used to classify deaths as suicides. In the previous 
study deaths were only classified as suicides if a note was found (Poulin et al., 1998). Dr. 
Bowes stated that as part of their determination of manner of death investigators take a 
more thorough approach, looking at multiple aspects, such as information from the 
families and social media sites that may give an indication of how that person was feeling 
prior to death (M. Bowes, Pers. Comm.). This more thorough method resulted in a 







efficient at determining manner of death as a suicide. There were other decreases before 
this time (from 56% in 2003 to 16 in 2005) which also indicates the possibility of other 
factors contributing to prevalence of suicides as manner of death in drug overdose (Figure 
3). 
 A major disadvantage when studying and comparing overdose deaths among 
studies is that death investigations vary among jurisdictions and medical examiners or 
coroners (Tatsumi et al., 2013).  
Prevalence of drugs was calculated based on drugs found in toxicology reports 
that did not necessarily cause death. Although these data indicate which drugs are highly 
implicated in drug overdose death, they can skew results by over representing typical 
medications that are found in low amounts and that are not implicated in the cause of 
death such as acetaminophen which is a common pain releiver.   
 Gaining information on the rates of overdose death, the prevalence and changes in 
drugs found in the toxicology reports of overdose deaths as well as the manner of death 
provides insight into the drug problem in Halifax, Nova Scotia during a fifteen-year 
period. Based on these data, it is possible to form more effective prevention programs or 
alter current ones to better focus the issues of public safety on the area which are causing 
the most problems. Focusing more effort into the prescription monitoring programs and 
creating more ways to regulate prescription drugs would be warranted. By warning 
people of the dosing effects and possible side effects of drugs, accidental overdoses could 
be avoided. By determining the general trend in drug overdose deaths specific areas can 
then be concentrated on. 







Scotia or Canada, which would enable provincial and national laws to be re-evaluated 
regarding drugs and public health and safety. These could then be models for areas 
outside of Canada as well. Future studies could be on examining factors which my affect 
the determination of a death due to overdose such as, decomposition. Examining why 


























 Drug overdose deaths have been increasing since 1993 in Halifax, Nova Scotia 
which is of concern to public health. Along with this increase in overdose death is the 
increased prevalence of many prescription medications such as narcotic analgesics and 
benzodiazepines, two of the most prevalent drugs in the toxicology results of overdose 
deaths. Since 1993 there has been an increase in accidental overdose deaths which also 
correlated with a decrease in undetermined deaths, resulting from a more thorough system 
investigation system. By studying these changes of the important aspects in drug 
overdose death it is possible to form more effective prevention of these deaths. Similar 
data collection and analysis done provincially or nationally could result in laws being 
changed and could serve as a model for other areas. A more in depth look at drug 
categories and overdose death determination would aid in monitoring drug overdose 
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Appendix A- Interpolation of population size data for Halifax, N.S. from 1996-2010 
 











































Appendix B- Total overdose deaths per year, 1996-2010 








































Appendix C- Drug categories and the list of drugs contained in those categories 
Ethanol methanol and isopropanol antidepresssants drugs available without prescriptionnarcotic analgesics benzodiazepines
Methanol amitriptyline acetaminophen codeine 7-aminoclonazepam
Isopropanol bupropion HCL diphenhydramine dihydrocodeine/hydrocodol alpha-hydroxyalprazolam
n-propanol desmethyldoxepin ibuprofen hydromorphone alprazolam
formic acid doxepin salicylate levomethophan bromazepam
formate citalopram dextromethorphan meperidine chlordiazepoxide
clomipramine dextrorphan methadone clonazepam
cotinine doxylamine levorphan diazepam
desipramine meclizine morphine hydroxytriazolam
desmethylclomipramine methocarbamol fentanyl lorazepam
desmethylsertaline naproxen oxymorphone midalozam
desmethyltrimipramine theobromine oxycodone nordiazepam



















drugs for major psychological and neurological disorders hypnotics and sedatives other prescription medicinescocaine cannabis miscellaneous
8-hydroxy-loxapine butalbital insulin benzoylecgonine carboxy-THC acetaldehyde
buspirone chloral hydrate acebutolol ecgonine ethyl ester cannabinoids caffeine
carbamazepine pentobarbital amlodipine methylecgonine delta-9 carboxy THC ehtylene glycol
clozapine phenobarbital atropine norcocaine delta-9 THC glycolic acid
haloperdiol propofol benztropine cocaethylene THC isovaleraldehyde
lithium secobarbitol bupivacaine nicotine
loxapine trichloroethanol Coumadin/Warfarin methyl ethyl ketone
methotrimeprazine zopiclone chlorpheniramine isoamyl alcohol




























                                  
Stimulants w/ cocaine Carbon Monoxide Hallucinogens
benzoylecgonine carboxyhemoglobin anhydro EME- psychedelic
ecgonine ethyl ester EME- psychedelic
methylecgonine phencyclidine- hallucinogen
norcocaine
cocaethylene
amphetamines
epinephrine
methamphetamine
cinnamoylococaine
TFMPP
phenyl propanolamine
norpseudoephedrine
pseudoephedrine
MDMA
MDA
BZP
 
